Embryo reduction versus expectant management in triplet pregnancies

Area of Science:

• Maternal-fetal medicine
• Reproductive medicine
• Perinatology

Background:

• Triplet pregnancies carry higher risks for both mother and neonate.
• Expectant management of triplets often leads to adverse outcomes like preterm birth and low birth weight.
• Embryo reduction is a potential intervention to mitigate these risks.

Purpose of the Study:

• To compare pregnancy outcomes between expectant management and embryo reduction to twins in triplet pregnancies.
• To evaluate the impact of embryo reduction on gestational age, birth weight, and infant complications.
• To assess the trade-offs between improved infant outcomes and increased fetal loss.

Main Methods:

• Retrospective study of 255 trichorionic triplet pregnancies.
• Comparison between 185 pregnancies undergoing embryo reduction to twins and 70 managed expectantly.
• Analysis of pregnancy outcomes including gestational age, birth weight, preterm delivery rates, low birth weight incidence, and fetal loss.

Main Results:

• Reduced pregnancies had significantly higher median birth weight (2300g vs 1760g) and prolonged gestation (36 vs 33 weeks).
• Significantly lower rates of preterm delivery (<32 weeks: 11.17% vs 36.76%; <35 weeks: 40.58% vs 83.82%) and low birth weight (<1500g: 10.98% vs 28.44%; <2500g: 68.55% vs 92.89%) were observed in the reduced group.
• Total fetal loss was significantly higher in the reduced group (15.41% vs 4.76%), primarily due to increased miscarriage rates.

Conclusions:

• Embryo reduction in triplet pregnancies significantly decreases severe preterm delivery and very low birth weight.
• The procedure leads to a significant increase in total fetal loss.
• Embryo reduction is likely to reduce the incidence of severe handicaps in infants resulting from extreme prematurity.